Thrombin Activatable Fibrinolysis Inhibitor in Thrombotic Complications of Systemic Lupus Erythematosus
Jackline Samir Kamal Fahim;
Abstract
SUMMARY AND CONCLUSION
Systemic lupus erythematosus is a chronic multisystem autoimmune disease with a broad range of clinical manifestations. The prevalence of vascular events in SLE patients ranges between 10% and 30%, for symptomatic coronary artery di
Systemic lupus erythematosus is a chronic multisystem autoimmune disease with a broad range of clinical manifestations. The prevalence of vascular events in SLE patients ranges between 10% and 30%, for symptomatic coronary artery di
Other data
| Title | Thrombin Activatable Fibrinolysis Inhibitor in Thrombotic Complications of Systemic Lupus Erythematosus | Other Titles | ثرومبين المـانع تنشيط انحلال الفيبرين فى مضاعفات الجلطات لمرض الذئبة الحمراء | Authors | Jackline Samir Kamal Fahim | Keywords | Thrombin Activatable Fibrinolysis Inhibitor in Thrombotic Complications of Systemic Lupus Erythematosus | Issue Date | 2013 | Description | SUMMARY AND CONCLUSION Systemic lupus erythematosus is a chronic multisystem autoimmune disease with a broad range of clinical manifestations. The prevalence of vascular events in SLE patients ranges between 10% and 30%, for symptomatic coronary artery di |
Attached Files
| File | Size | Format | |
|---|---|---|---|
| 116703g283.pdf | 376.89 kB | Adobe PDF | View/Open |
Similar Items from Core Recommender Database
Items in Ain Shams Scholar are protected by copyright, with all rights reserved, unless otherwise indicated.